DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low magnesium, Low Calcium and attached...

FDA Drug Recall #D-0609-2021 — Class III — April 28, 2021

Recall Summary

Recall Number D-0609-2021
Classification Class III — Low risk
Date Initiated April 28, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fresenius Medical Care Holdings, Inc.
Location Waltham, MA
Product Type Drugs
Quantity 4 cases

Product Description

DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low magnesium, Low Calcium and attached stay safe Exchange set, 2000 mL, packs of 5, Rx only, Fresenius Medical Care NA, Waltham, MA 02451, NDC 49230-212-92

Reason for Recall

Temperature Abuse: Product exposed to temperature outside specified limits.

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot #: 20PU04030, Exp. date June 2022

Other Recalls from Fresenius Medical Care Holdings, Inc.

Recall # Classification Product Date
D-0490-2025 Class II 0.9% Sodium Chloride Injection, USP, Flexible P... May 27, 2025
D-0608-2024 Class II DELFLEX PERITONEAL DIALYSIS SOLUTION With LOW M... Jun 18, 2024
D-0218-2024 Class II DELFLEX Peritoneal Dialysis Solution in Biofine... Dec 28, 2023
D-0777-2023 Class II Sodium Chloride 0.9% Injection, USP, 1000 mL ba... May 23, 2023
D-0075-2023 Class II 0.9% Sodium Chloride Injection, USP, Each 100 m... Nov 22, 2022

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.